Incidence of thrombotic complications in critically ill ICU patients with COVID-19

Klok, F.A., Kruip, M.J.H.A., van der Meer, N.J.M., Arbous, M.S., Gommers, D.A.M.P.J., Kant, K.M., Kaptein, F.H.J., van Paassen, J. +3 more·2020·Thrombosis Research

Cited by (1,012)

Items 701–800 of 1,012

  1. The different manifestations of COVID-19 in adults and children: a cohort study in an intensive care unit
    on behalf of the KIDS-Corona study group, Mònica Girona‐Alarcón, Kids Corona Platform, Sara Bobillo‐Pérez, Anna Solé‐Ribalta, Lluïsa Hernández, Carmina Guitart, Ricardo Suárez, Mònica Balaguer, Francisco José Cambra Lasaosa et al. · 2021 · BMC Infectious Diseases
  2. A systematic review and meta-analysis of incidence, prognosis, and laboratory indicators of venous thromboembolism in hospitalized patients with coronavirus disease 2019
    Yandong Liu, Jiawei Cai, Chao Wang, Jie Jin, Lefeng Qu · 2021 · Journal of Vascular Surgery Venous and Lymphatic Disorders
  3. Mechanisms of immunothrombosis in COVID-19
    Irina Portier, Robert A. Campbell, Frederik Denorme · 2021 · Current Opinion in Hematology
  4. Underlying mechanisms of thrombus formation/growth in atherothrombosis and deep vein thrombosis
    Atsushi Yamashita, Yujiro Asada · 2023 · Pathology International
  5. Longitudinal Peripheral Blood Transcriptional Analysis Reveals Molecular Signatures of Disease Progression in COVID-19 Patients
    Qihong Yan, Pingchao Li, Xianmiao Ye, Xiaohan Huang, 莫晓能, Qian Wang, Yudi ZHANG, Luo Kun, Zhaoming Chen, Jia Luo et al. · 2021 · The Journal of Immunology
  6. Emergence of institutional antithrombotic protocols for coronavirus 2019
    Kevin P. Cohoon, Guillaume Mahé, Alfonso Javier Tafur, Alex C. Spyropoulos · 2020 · Research and Practice in Thrombosis and Haemostasis
  7. Thrombosis and coagulopathy in COVID‐19: An illustrated review
    Marcel M Levi, Beverley Jane Hunt · 2020 · Research and Practice in Thrombosis and Haemostasis
  8. Characteristics and Outcomes of In-Hospital Cardiac Arrest Events During the COVID-19 Pandemic
    Jeremy A. Miles, Mateo Mejía Saldarriaga, Saul A. Rios, Seth I. Sokol, Matthew Langston, Steven R. Hahn, Ephraim Leiderman, Reka Salgunan, Israa Soghier, Perminder Gulani et al. · 2020 · Circulation Cardiovascular Quality and Outcomes
  9. Prone positioning for patients with hypoxic respiratory failure related to COVID-19
    Kevin Venus, Laveena Munshi, Michael Fralick · 2020 · Canadian Medical Association Journal
  10. Demographic & clinical profile of patients with COVID-19 at a tertiary care hospital in north India
    Shiv Lal Soni, Kamal Kajal, Lakshmi Narayana Yaddanapudi, Pankaj Malhotra, Goverdhan Dutt Puri, Ashish Bhalla, Mini Pritam Singh, Inderpaul Singh Sehgal, Vipin Koushal, Neelam Varma et al. · 2021 · The Indian Journal of Medical Research
  11. Endothelialitis plays a central role in the pathophysiology of severe COVID-19 and its cardiovascular complications
    Christiaan J. Vrints, Konstantin Alexander Krychtiuk, Emeline M. Van Craenenbroeck, Vincent F. M. Segers, Susanna Price, Hein Heidbüchel · 2020 · Acta cardiologica. Supplementum
  12. COVID-19 grave: entenda o papel da imunidade, do endotélio e da coagulação na prática clínica
    Simone Cristina Soares Brandão, Emmanuelle Tenório Albuquerque Madruga Godoi, Júlia de Oliveira Xavier Ramos, Leila Maria Magalhães Pessoa de Melo, EMANUEL SÁVIO CAVALCANTI SARINHO · 2020 · Jornal Vascular Brasileiro
  13. T Cell Activation, Highly Armed Cytotoxic Cells and a Shift in Monocytes CD300 Receptors Expression Is Characteristic of Patients With Severe COVID-19
    Olatz Zenarruzabeitia, Gabirel Astarloa-Pando, Iñigo Terrén, Ane Orrantia, Raquel Pérez-Garay, Iratxe Seijas, Javier Nieto Arana, Natale Imaz-Ayo, Sílvia Pérez-Fernández, Eunate Arana‐Arri et al. · 2021 · Frontiers in Immunology
  14. Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries
    Marijke Linschoten, Alicia Uijl, Astrid Schut, C E M Jakob, L R Romão, RM Bell, Ewan McFarlane, Melanie Stecher, Anna G M Zondag, Erik P.A. van Iperen et al. · 2021 · European Heart Journal
  15. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis
    The Task Force for the management of COVID-19 of the European Society of Cardiology, Colin Baigent, Stephan Windecker, Daniele Andreini, Elena Arbelo, Emanuele Barbato, Antonio Luca Bartorelli, Andreas Baumbach, Elijah Raphael Behr, Sérgio Luis Berti et al. · 2021 · Cardiovascular Research
  16. Heparin Resistance During Cardiopulmonary Bypass in Adult Cardiac Surgery
    Yufan Chen, Priscilla Hui Yi Phoon, Nian Chih Hwang · 2022 · Journal of Cardiothoracic and Vascular Anesthesia
  17. Critically ill COVID-19 patient
    Burçin Halaçlı, Akın Kaya, Arzu Topeli̇ · 2020 · TURKISH JOURNAL OF MEDICAL SCIENCES
  18. Parenteral fish oil: An adjuvant pharmacotherapy for coronavirus disease 2019?
    Raquel Susana Torrinhas, Philip C. Calder, Gabriela Lemos, Dan Linetzky Waitzberg · 2020 · Nutrition
  19. Serial measurements in COVID-19-induced acute respiratory disease to unravel heterogeneity of the disease course: design of the Maastricht Intensive Care COVID cohort (MaastrICCht)
    Maastricht Intensive Care COVID Study Group; MaastrICCht Collaborators, Jeanette Tas, Rob J. J. van Gassel, Serge J Heines, Mark M. G. Mulder, Nanon F. L. Heijnen, Melanie J. de Jong, Julia L.M. Bels, Frank C. Bennis, Marcel Koelmann et al. · 2020 · BMJ Open
  20. Coagulation Disorders and Thrombosis in COVID-19 Patients and a Possible Mechanism Involving Endothelial Cells: A Review
    An‐Tian Chen, Chenyu Wang, Wen-ling Zhu, Wei Chen · 2022 · Aging and Disease
  21. Venous thromboembolism in SARS-CoV-2 patients: only a problem in ventilated ICU patients, or is there more to it?
    Maarten Criel, Maarten Falter, Jasmien Jaeken, Margaretha Van Kerrebroeck, Isabelle Lefere, L Meylaerts, Dieter Mesotten, Margot Vander Laenen, Tom Fivez, Michiel Thomeer et al. · 2020 · European Respiratory Journal
  22. Bivalirudin for Maintenance Anticoagulation During Venovenous Extracorporeal Membrane Oxygenation for COVID-19
    Troy G. Seelhammer, Phillip G. Rowse, Suraj M. Yalamuri · 2020 · Journal of Cardiothoracic and Vascular Anesthesia
  23. MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale
    Paul Ellis Marik, Pierre D. Kory, Joseph Varón, Jose I. Iglesias, G. Umberto Meduri · 2020 · Expert Review of Anti-infective Therapy
  24. D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19
    Justin J. Choi, Graham T. Wehmeyer, Han A. Li, Mark N. Alshak, Musarrat Nahid, Mangala Rajan, Bethina Liu, Emma M. Schatoff, Rahmi Elahjji, Youmna Abdelghany et al. · 2020 · Thrombosis Research
  25. Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets
    Harry Karmouty‐Quintana, Rajarajan A. Thandavarayan, Steven P. Keller, Sandeep Sahay, Lavannya M. Pandit, Bindu H. Akkanti · 2020 · International Journal of Molecular Sciences
  26. COVID ‐19, thromboembolic risk, and Virchow's triad: Lesson from the past
    Jawahar Lal Mehta, Giuseppe Calcaterra, Pier Paolo Bassareo · 2020 · Clinical Cardiology
  27. COVID‐19 pathogenesis, prognostic factors, and treatment strategy: Urgent recommendations
    Bin Zhou, Shinsuke Kojima, Atsuhiko Kawamoto, Masanori Fukushima · 2020 · Journal of Medical Virology
  28. Pulmonary Vascular Thrombosis in COVID-19 Pneumonia
    Francesco DE COBELLI, Diego Palumbo, Fabio Ciceri, Giovanni Landoni, Annalisa Ruggeri, Patrizia Querini Rovere, Armando D’Angelo, Stephanie Steidler, Laura Galli, Andrea Poli et al. · 2021 · Journal of Cardiothoracic and Vascular Anesthesia
  29. Incidence and impact of disseminated intravascular coagulation in COVID-19 a systematic review and meta-analysis
    Xianghui Zhou, Zhipeng Cheng, Lili Luo, Ying Zhu, Wenyi Lin, Zhangyin Ming, Wei Chen, Yu Hu · 2021 · Thrombosis Research
  30. SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction
    Raffaele Marfella, Pasquale Paolisso, Celestino Sardu, Luciana Palomba, Nunzia D’Onofrio, Arturo Cesaro, Michelangela Barbieri, Maria Rosaria Rizzo, Ferdinando Carlo Sasso, Lucia Scisciola et al. · 2021 · Critical Care
  31. Incidence of thrombotic complications in COVID-19
    William John Jenner, Diana Adrienne Gorog · 2021 · Journal of Thrombosis and Thrombolysis
  32. Comprehensive Landscape of Heparin Therapy for COVID-19
    Chen Shi, Tingting Wu, Jin-Ping Li, Mitchell Anthony Sullivan, Cong Wang, Hanxiang Wang, Bin Deng, Yu Zhang · 2020 · Carbohydrate Polymers
  33. Hospitalized COVID-19 Patients and Venous Thromboembolism
    Alex C. Spyropoulos, Jeffrey Ian Weitz · 2020 · Circulation
  34. Atypical Deep Cerebral Vein Thrombosis with Hemorrhagic Venous Infarction in a Patient Positive for COVID-19
    Lydia Chougar, Bertrand Mathon, Nicolas Weiss, Vincent Degos, Natalia Shor · 2020 · American Journal of Neuroradiology
  35. Functional respiratory imaging identifies redistribution of pulmonary blood flow in patients with COVID-19
    Muhunthan Thillai, Chinmay Patvardhan, Emilia M. Swietlik, Tom McLellan, Jan De Backer, Maarten Lanclus, Wilfried De Backer, Alessandro Ruggiero · 2020 · Thorax
  36. Can symptoms of anosmia and dysgeusia be diagnostic for COVID‐19?
    Syeda Anum Zahra, Sashini Iddawela, Kiran Pillai, Rozina Yasmin Choudhury, Amer Harky · 2020 · Brain and Behavior
  37. COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management
    Md. Farhad Hossain, Sharifa Hasana, Abdullah Al Mamun, Md. Sahab Uddin, Mir Imam Ibne Wahed, Sabarni Sarker, Tapan Behl, Irfan Ullah, Yesmin Begum, Israt Jahan Bulbul et al. · 2020 · Frontiers in Pharmacology
  38. Coagulation abnormalities in SARS-CoV-2 infection: overexpression tissue factor
    Zahra Eslamifar, Mahin Behzadifard, Masoud Soleimani, Saba Behzadifard · 2020 · Thrombosis Journal
  39. N-Acetylcysteine and Hydrogen Sulfide in Coronavirus Disease 2019
    Arno R. Bourgonje, Annette K. Offringa, Larissa E. van Eijk, Amaal Eman Abdulle, Jan‐Luuk Hillebrands, Peter H. J. van der Voort, Harry van Goor, Ed. J. Van Hezik · 2021 · Antioxidants and Redox Signaling
  40. Mortality trends among hospitalised COVID-19 patients in Sweden: A nationwide observational cohort study
    Kristoffer Strålin, Erik H. Wahlstrom, Sten Walther, Anna M. Bennet, Mona Heurgren, Thomas K. A. Linden, Johanna Holm, Håkan Hanberger · 2021 · The Lancet Regional Health - Europe
  41. A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19
    Emmanuelle Logette, Charlotte Lorin, Cyrille Favreau, Eugenia Oshurko, Jay S. Coggan, Francesco Casalegno, Mohameth François Sy, Caitlin Monney, Marine Bertschy, Émilie Delattre et al. · 2021 · Frontiers in Public Health
  42. Clinical features of thrombosis and bleeding in COVID-19
    Mari R. Thomas, Marie Scully · 2022 · Blood
  43. Proximal deep vein thrombosis and pulmonary embolism in COVID-19 patients: a systematic review and meta-analysis
    Grégoire Longchamp, Sara Manzocchi Besson, Alban Longchamp, Marc Righini, Helia Robert‐Ebadi, Marc Blondon · 2021 · Thrombosis Journal
  44. TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2
    Dhriti Kaushik, Ranjana Bhandari, Anurag Kuhad · 2021 · Expert Opinion on Therapeutic Targets
  45. Clinical characteristics of acute lower extremity deep venous thrombosis diagnosed by duplex in patients hospitalized for coronavirus disease 2019
    Issam Koleilat, Benjamin T Galen, Krystina Choinski, Ayesha Nzeribe Hatch, Davis Brent Jones, Henny Heisler Billett, Jeff Indes, Evan C. Lipsitz · 2020 · Journal of Vascular Surgery Venous and Lymphatic Disorders
  46. Acute Stroke Management During the COVID-19 Pandemic
    Steven David Hajdu, Valerie E. H. Pittet, Francesco Puccinelli, Wagih Ben Hassen, Malek Ben Maacha, Raphaël Blanc, Sandra Bracco, Gabriel Broocks, Bruno Mario Bartolini, Tommaso Casseri et al. · 2020 · Stroke
  47. Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic
    Benjamin Marchandot, Antonin Trimaille, Anaïs Curtiaud, Kensuke Matsushita, Laurence Jesel, Olivier Morel · 2020 · Journal of Thrombosis and Thrombolysis
  48. Prospective Longitudinal Evaluation of Point‐of‐Care Lung Ultrasound in Critically Ill Patients With Severe COVID ‐19 Pneumonia
    Abdulrahman Mishaal Alharthy, Fahad Ali Faqihi, Mohamed Abuhamdah, Alfateh Sayed Nasr Noor, Nasir Nasim Mahmood, Abdullah Balhamar, Ahad Alhassan Al Saud, Peter George Brindley, Ziad Ahmed Memish, Dimitrios Karakitsos et al. · 2020 · Journal of Ultrasound in Medicine
  49. Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study
    Khalid A. Al Sulaiman, Ohoud A. Aljuhani, Khalid Bin Saleh, Hisham A. Badreldin, Abdullah Al Harthi, Mohammed Alenazi, Aisha A. Alharbi, Rahmah Algarni, Shmeylan A. Al Harbi, Abdullah Alhammad et al. · 2021 · Scientific Reports
  50. C-type lectins and extracellular vesicles in virus-induced NETosis
    Pei‐Shan Sung, Shie-Liang Edmond Hsieh · 2021 · Journal of Biomedical Science
  51. Platelets in Viral Infections – Brave Soldiers or Trojan Horses
    Waltraud C. Schrottmaier, Anna Schmuckenschlager, Anita Pirabe, Alice Assinger · 2022 · Frontiers in Immunology
  52. Glutathione deficiency in the pathogenesis of SARS-CoV-2 infection and its effects upon the host immune response in severe COVID-19 disease
    Carlos Alberto Labarrere, Ghassan S. Kassab · 2022 · Frontiers in Microbiology
  53. Proposed Mechanisms of Targeting COVID-19 by Delivering Mesenchymal Stem Cells and Their Exosomes to Damaged Organs
    Elham Jamshidi, Amirhesam Babajani, Pegah Soltani, Hassan Niknejad · 2021 · Stem Cell Reviews and Reports
  54. Anti-coagulant and anti-platelet therapy in the COVID-19 patient: a best practices quality initiative across a large health system
    Ryan A. Watson, Drew M. Johnson, Robin N. Dharia, Geno J. Merli, John U. Doherty · 2020 · Hospital Practice
  55. Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia
    Luca Costanzo, Francesco Paolo Palumbo, Giorgio Ardita, Pier Luigi Antignani, Enrico Arosio, Giacomo Failla · 2020 · Journal of Vascular Surgery Venous and Lymphatic Disorders
  56. Pulmonary Thromboembolism in COVID-19: Venous Thromboembolism or Arterial Thrombosis?
    Enrico Cavagna, Francesco Muratore, Fabio Ferrari · 2020 · Radiology Cardiothoracic Imaging
  57. Neurologic complications of COVID-19
    Catherine E. Hassett, Aron Gedansky, Ibrahim Migdady, Adarsh Bhimraj, Ken Uchino, Sung‐Min Cho · 2020 · Cleveland Clinic Journal of Medicine
  58. Pathogenesis‐directed therapy of 2019 novel coronavirus disease
    Charles W. Stratton, Yi‐Wei Tang, Hongzhou Lu · 2020 · Journal of Medical Virology
  59. A Systematic Review of the Cardiovascular Manifestations and Outcomes in the Setting of Coronavirus-19 Disease
    Samarthkumar J. Thakkar, Shilpkumar Arora, Ashish Kumar, Rahul Jaswaney, Mohammed Faisaluddin, Mohammad Ammad Ud Din, Mariam Shariff, Kirolos N. Barssoum, Harsh Patel, Nirav Arora et al. · 2020 · Clinical Medicine Insights Cardiology
  60. Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted
    Pobitra Borah, Pran Kishore Deb, Balakumar Chandrasekaran, Manoj Goyal, Monika Bansal, Snawar Hussain, Pottathil Shinu, Katharigatta Narayanaswamy Venugopala, Nizar A. Al‐Shar’i, Satyendra Deka et al. · 2021 · Frontiers in Molecular Biosciences
  61. Bleeding risk in hospitalized patients with COVID‐19 receiving intermediate‐ or therapeutic doses of thromboprophylaxis
    Pablo Demelo Rodríguez, Ana Isabel Farfán‐Sedano, José María Pedrajas, Pilar Llamas, Patricia Sigüenza, María Jesús Jaras, Manuel Quintana‐Díaz, Carmen Fernández‐Capitán, Behnood Bikdeli, David Jiménez et al. · 2021 · Journal of Thrombosis and Haemostasis
  62. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up
    The Task Force for the management of COVID-19 of the European Society of Cardiology, Colin Baigent, Stephan Windecker, Daniele Andreini, Elena Arbelo, Emanuele Barbato, Antonio Luca Bartorelli, Andreas Baumbach, Elijah Raphael Behr, Sérgio Luis Berti et al. · 2021 · Cardiovascular Research
  63. Superior Mesenteric Arterial and Venous Thrombosis in COVID-19
    Amaravathi, Uthayakumar, Balamurugan, Nathan, Muthu Pillai, Vivekanandan, Ayyan, S. Manu · 2021 · The Journal of Emergency Medicine
  64. The struggle of a good friend getting old: cellular senescence in viral responses and therapy
    Kohli, Jaskaren, Veenstra, Iris, Demaria, Marco · 2021 · The EMBO Reports
  65. Understanding the COVID‐19 coagulopathy spectrum
    Jecko V. Thachil, Seema Agarwal · 2020 · Anaesthesia
  66. Multisystemic Infarctions in COVID-19: Focus on the Spleen
    Mariana Santos Leite Pessoa, Carla Franco Costa Lima, Ana Carla Farias Pimentel, José Carlos Godeiro Costa Júnior, Jorge Luís Bezerra Holanda · 2020 · European Journal of Case Reports in Internal Medicine
  67. Targeting Macrophages as a Therapeutic Option in Coronavirus Disease 2019
    Maria Gracia-Hernandez, Eduardo M. Sotomayor, Alejandro Villagra · 2020 · Frontiers in Pharmacology
  68. Acute myocardial infarction secondary to COVID-19 infection: A case report and review of the literature
    Kathleen M. Capaccione, Jay S. Leb, Belinda M. D’Souza, Pallavi S. Utukuri, Mary M. Salvatore · 2020 · Clinical Imaging
  69. Psychological and neuropsychiatric implications of COVID-19
    Elizabeta Blagoja Mukaetova-Ladinska, Golo Kronenberg · 2020 · European Archives of Psychiatry and Clinical Neuroscience
  70. Acute disseminated encephalomyelitis (ADEM) associated with COVID-19
    Lawrence Langley, Claudia Zeicu, Louise Whitton, Mathilde M. H. Pauls · 2020 · BMJ Case Reports
  71. Higher anticoagulation targets and risk of thrombotic events in severe COVID-19 patients: bi-center cohort study
    Julie Helms, François Séverac, Hamid Merdji, Maleka Schenck, Raphaël Clère-Jehl, Mathieu Baldacini, Mickaël Ohana, L. Grunebaum, Vincent Castelain, Eduardo Anglés‐Cano et al. · 2021 · Annals of Intensive Care
  72. Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19
    Bertram Pitt, Nadia R. Sutton, Zhong Wang, Sascha N. Goonewardena, Michael A. Holinstat · 2021 · European Journal of Pharmacology
  73. CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation
    Pei‐Shan Sung, Shao-Ping Yang, Yu-Chun Peng, Cheng‐Pu Sun, Mi‐Hua Tao, Shie-Liang Edmond Hsieh · 2022 · Journal of Biomedical Science
  74. Therapeutic plasma exchange in adult critically ill patients with life-threatening SARS-CoV-2 disease: A pilot study
    Fahad Ali Faqihi, Abdulrahman Mishaal Alharthy, Mohammed Ali Al-Odat, Demetrios James Kutsogiannis, Peter George Brindley, Dimitrios Karakitsos · 2020 · Journal of Critical Care
  75. Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020
    Souheil Zayet, Timothée Klopfenstein, Róbert Kovẚcs, Silviu Stancescu, Beate Hagenkötter · 2020 · Emerging infectious diseases
  76. P-selectin blockade in COVID-19-related ARDS
    Tommaso Neri, Dario Nieri, Alessandro Celi · 2020 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  77. Incidence of Venous Thromboembolism in Hospitalized Coronavirus Disease 2019 Patients: A Systematic Review and Meta-Analysis
    Chi Zhang, Long Shen, Ke-Jia Le, Mang-Mang Pan, Ling-Cong Kong, Zhi‐Chun Gu, Hang Xu, Zhen Zhang, Weihong Ge, Hou‐Wen Lin · 2020 · Frontiers in Cardiovascular Medicine
  78. Clinical Characteristics, Hospitalization, and Mortality Rates of Coronavirus Disease 2019 Among Liver Transplant Patients in the United States: A Multicenter Research Network Study
    Emad Mansoor, Abe Perez, Mohannad Abou Saleh, Seth N. Sclair, Stanley Cohen, Gregory S. Cooper, Alexandra M Mills, Kayla Schlick, Ahmad Khan · 2020 · Gastroenterology
  79. Anticoagulation in Hospitalized Patients with Covid-19
    Jehan F. Chowdhury, Lisa K. Moores, Jean M. Connors · 2020 · New England Journal of Medicine
  80. Risk Management and Treatment of Coagulation Disorders Related to COVID-19 Infection
    Christian Zanza, Fabrizio Racca, Yaroslava Longhitano, Andrea Piccioni, Francesco Franceschi, Marco Artico, Ludovico Abenavoli, Aniello Maiese, Giovanna Passaro, Gianpietro Volonnino et al. · 2021 · International Journal of Environmental Research and Public Health
  81. Clinical characteristics and outcomes of 952 hospitalized COVID-19 patients in The Netherlands: A retrospective cohort study
    Niels Pouw, Josephine van de Maat, Karin M. Veerman, Jaap ten Oever, Nico A. F. Janssen, Evertine J. Abbink, Monique H E Reijers, Quirijn de Mast, Wouter Hoefsloot, Reinout van Crevel et al. · 2021 · PLoS ONE
  82. Acute Kidney Injury and Acute Respiratory Distress Syndrome
    Bryan D. Park, Sarah G. Faubel · 2021 · Critical Care Clinics
  83. Neurological complications associated with Covid‐19; molecular mechanisms and therapeutic approaches
    Mohammad Mahboubi Mehrabani, Mohammad Sobhan Karvandi, Pedram Maafi, Mohammad Doroudian · 2022 · Reviews in Medical Virology
  84. Neurological consequences of COVID-19
    Waldemar Brola, Maciej Wilski · 2022 · Pharmacological Reports
  85. The “pandemic” increase in lung ultrasound use in response to Covid-19: can we complement computed tomography findings? A narrative review
    Luigi Vetrugno, Marco Baciarello, Elena Giovanna Bignami, Andrea Bonetti, Francesco Saturno, Daniele Orso, Rossano Girometti, Lorenzo Cereser, Tiziana Bove · 2020 · The Ultrasound Journal
  86. Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19
    Lucas C. Godoy, Ewan C. Goligher, Patrick R. Lawler, Arthur S. Slutsky, Ryan Zarychanski · 2020 · Canadian Medical Association Journal
  87. Potential for Cognitive Communication Impairment in COVID-19 Survivors: A Call to Action for Speech-Language Pathologists
    Amy E. Ramage · 2020 · American Journal of Speech-Language Pathology
  88. Lung ultrasound and computed tomography to monitor COVID-19 pneumonia in critically ill patients: a two-center prospective cohort study
    Micah L. A. Heldeweg, Jorge E. López Matta, Mark Evert Haaksma, Jasper M. Smit, Carlos V. Elzo Kraemer, Harm‐Jan de Grooth, Evert de Jonge, Lilian J. Meijboom, Leo M. A. Heunks, David Johannes van Westerloo et al. · 2021 · Intensive Care Medicine Experimental
  89. Digital Ischemia in COVID-19 Patients: Case Report
    Kathryn Schultz, Jennifer Moriatis Wolf · 2020 · The Journal Of Hand Surgery
  90. ADL-dependency, D-Dimers, LDH and absence of anticoagulation are independently associated with one-month mortality in older inpatients with Covid-19
    Guilhem Bousquet, Géraldine Falgarone, David Deutsch, Sophie Derolez, Marilucy Lopez‐Sublet, François‐Xavier Goudot, Khadaoudj Amari, Y. Uzunhan, Olivier Bouchaud, Frédéric Pamoukdjian · 2020 · Aging
  91. COVID-19: The crucial role of blood coagulation and fibrinolysis
    SERGIO COCCHERI · 2020 · Internal and Emergency Medicine
  92. Hemostatic alterations in COVID-19
    Flora Peyvandi, Andrea Artoni, Cristina Novembrino, Stefano Aliberti, Mauro Panigada, Marco Boscarino, Roberta Gualtierotti, Federica Rossi, Roberta Palla, Ida Martinelli et al. · 2020 · Haematologica
  93. Late acute pulmonary embolism after mild Coronavirus Disease 2019 (COVID-19): a case series
    Hareton Teixeira Vechi, Lucas Rodrigues Maia, Manoella do Monte Alves · 2020 · Revista do Instituto de Medicina Tropical de São Paulo
  94. Stroke in Coronavirus Disease 2019: A Systematic Review
    Rohit Bhatia, Radhakrishna Pedapati, Snigdha Komakula, M.V. Padma Srivastava, Sreenivas Vishnubhatla, Dheeraj Khuranac · 2020 · Journal of Stroke
  95. The Use of Therapeutic-Dose Anticoagulation and Its Effect on Mortality in Patients With COVID-19: A Systematic Review
    Indra Wijaya, Rizky Andhika, Ian Huang · 2020 · Clinical and Applied Thrombosis/Hemostasis
  96. Environmental Issues and Neurological Manifestations Associated with COVID-19 Pandemic: New Aspects of the Disease?
    Luigi Bellocchio, Ioana Roxana Bordea, Andrea Ballini, Felice Lorusso, Denisa Hazballa, Ciro Gargiulo Isacco, Giuseppina Malcangi, Alessio Danilo Inchingolo, Gianna Dipalma, Francesco Inchingolo et al. · 2020 · International Journal of Environmental Research and Public Health
  97. Systematic review and meta-analysis of the prevalence of venous thromboembolic events in novel coronavirus disease-2019 patients
    Rui Zhang, Leng Ni, Xiao Di, Xuebin Wang, Baitao Ma, Shuai Niu, Changwei Liu · 2020 · Journal of Vascular Surgery Venous and Lymphatic Disorders
  98. ACE Gene I/D Polymorphism and Acute Pulmonary Embolism in COVID19 Pneumonia: A Potential Predisposing Role
    C. Calabrese, A. Annunziata, A. Coppola, P. Pafundi, Salvatore Guarino, V. Di Spirito, V. Maddaloni, N. Pepe, G. Fiorentino · 2021 · Frontiers in Medicine
  99. Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID‐19: Insight From a French Multicenter Cohort Study
    Richard Chocron, Vincent Galand, Joffrey Cellier, Nicolas Gendron, Thibaut Pommier, Olivier Bory, Lina Khider, Antonin Trimaille, Guillaume Goudot, Orianne Weizman et al. · 2021 · Journal of the American Heart Association
  100. The COVID Complex: A Review of Platelet Activation and Immune Complexes in COVID-19
    Stefan D. Jevtic, Ishac Nazy · 2022 · Frontiers in Immunology